Below are the earnings highlights for Kiniksa Pharmaceuticals, Ltd. (KNSA):
Earnings: -$8.89 million in Q4 vs. $25.24 million in the same period last year.
EPS: -$0.12 in Q4 vs. $0.35 in the same period last year.
Analysts projected $0.13 per share
Revenue: $122.54 million in Q4 vs. $83.40 million in the same period last year.
For comments and feedback: editorial@rttnews.com